Hampshire BioLogix is a biotechnology subsidiary of Hampshire Pharmacy, focused on developing next-generation biologics and biosimilar therapies that improve patient outcomes while reducing treatment costs. Our research integrates molecular innovation with sustainable manufacturing, ensuring every product meets global quality and ethical standards. By combining scientific precision with digital automation, we’re building a more accessible and resilient healthcare future — one molecule at a time.